Return to homepagePandemic Pact

COVID-19: NIAID CLINICAL SITE MONITORING

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 272201700004C-P00010-9999-2

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022
    2023

  • Known Financial Commitments (USD)

    $912,600

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    KIMBERLY SMITH

  • Research Location

    United States of America

  • Lead Research Institution

    PPD DEVELOPMENT LP

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Vaccine design and administration

  • Special Interest Tags

    N/A

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The purpose of the Clinical Site Monitoring contract is to provide comprehensive clinical site and study monitoring services for the NIAID clinical trial research portfolio, including the delivery of monitoring services for unanticipated NIAID clinical research projects that may be required in response to emerging needs or public health emergencies. This project will provide clinical trial monitoring services for the COVID-19 clinical trial ACTIV-2 (Outpatient Monoclonal Antibodies And Other Therapies).